IE32197L - Pharmceutical composition - Google Patents

Pharmceutical composition

Info

Publication number
IE32197L
IE32197L IE83968A IE83968A IE32197L IE 32197 L IE32197 L IE 32197L IE 83968 A IE83968 A IE 83968A IE 83968 A IE83968 A IE 83968A IE 32197 L IE32197 L IE 32197L
Authority
IE
Ireland
Prior art keywords
silver
heavy metal
july
compositions
metal salt
Prior art date
Application number
IE83968A
Other versions
IE32197B1 (en
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Priority to IE426/72A priority Critical patent/IE32198B1/en
Publication of IE32197L publication Critical patent/IE32197L/en
Publication of IE32197B1 publication Critical patent/IE32197B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Abstract

1,240,546. Medicines containing antibiotics and sulphonamides. RESEARCH CORP. 16 July, 1968 [17 July, 1967], No. 49459/70. Divided out of 1,240,545. Heading A5B. A pharmaceutical composition comprises a heavy metal salt of an antibiotic in admixture with a heavy metal salt of a sulphonamide and/or silver salicylate. The heavy metal salts may be those of gold, nickel, tin, zinc, mercury, platinum, osmium, molybdenum, titanium, copper or silver (preferred). Specified are silver salts of penicillin, cephalothin, colistimethate, and tetracycline; and silver salts of sulphamerazine, sulphonanilide, sulphathiazole, sulphapyridine, sulphamylon, sulphoxazole, sulphapyrimidine, sulphaquinoxaline, substituted benzene sulphonamide and sulphamyl benzothiadiazine dioxide. The compositions may be in the form of a powder, an aqueous suspension, ointment, aerosol or may be incorporated in a film-forming material. Aqueous solutions containing chloride ions e.g. NaCl may be used as carriers for the active ingredients. Specification 1,240,545 is referred to. The compositions are useful in the treatment of burns.
IE83968A 1967-07-17 1968-07-15 Silver-containing therapeutic agents IE32197B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE426/72A IE32198B1 (en) 1967-07-17 1968-07-15 Improvements in or relating to antibacterial compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65383067A 1967-07-17 1967-07-17

Publications (2)

Publication Number Publication Date
IE32197L true IE32197L (en) 1969-01-17
IE32197B1 IE32197B1 (en) 1973-05-16

Family

ID=24622450

Family Applications (1)

Application Number Title Priority Date Filing Date
IE83968A IE32197B1 (en) 1967-07-17 1968-07-15 Silver-containing therapeutic agents

Country Status (8)

Country Link
BE (1) BE718183A (en)
DE (1) DE1792053B1 (en)
ES (1) ES356142A1 (en)
FR (2) FR1586125A (en)
GB (2) GB1240546A (en)
IE (1) IE32197B1 (en)
NL (1) NL6809794A (en)
PH (1) PH10639A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049802A (en) 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
DE2804931A1 (en) * 1978-02-06 1979-08-16 Fresenius Chem Pharm Ind METAL SULFADIAZINE IN FINE PARTICULAR FORM
US4384117A (en) * 1980-03-18 1983-05-17 The United States Of America As Represented By The Secretary Of The Army Silver metachloridine
US4933330A (en) * 1987-04-01 1990-06-12 Dak-Laboratoriet Benzoic acid derivatives and use thereof
CA2024220A1 (en) * 1990-08-29 1992-03-01 Don Simmons Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery
IT1243435B (en) * 1990-10-05 1994-06-10 Altergon Sa PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE INCLUDING HYALURONIC ACID SODIUM SALT AND DISINFECTANT SUBSTANCES
EA200400708A1 (en) 2001-11-22 2004-10-28 Биовитрум Аб INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1
US7173030B2 (en) 2003-05-21 2007-02-06 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
AU2004240885A1 (en) * 2003-05-21 2004-12-02 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
SE0301884D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use III
SE0301882D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use I
SE0301888D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use VII
SE0301886D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use V
SE0301885D0 (en) * 2003-06-25 2003-06-25 Biovitrum Ab New use IV
WO2004113310A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
BRPI1104620B1 (en) * 2011-09-09 2020-04-07 Lucia Teixeira De Carvalho pharmaceutical composition for the treatment of burns and skin lesions and their preparation process

Also Published As

Publication number Publication date
GB1240546A (en) 1971-07-28
FR1586125A (en) 1970-02-13
FR8146M (en) 1970-08-17
NL6809794A (en) 1969-01-21
PH10639A (en) 1977-07-22
BE718183A (en) 1969-01-17
GB1240545A (en) 1971-07-28
IE32197B1 (en) 1973-05-16
DE1792053B1 (en) 1971-07-29
ES356142A1 (en) 1970-02-16

Similar Documents

Publication Publication Date Title
FR8146M (en)
GB1410588A (en) Composition
GB1397073A (en) 1,2,4-oxadizoles
GB1422193A (en) Pharmaceutical compositions
GB1318478A (en) Cephalexin salts
GB1442772A (en) Inhibition of leukaemia utilizing 5-methyl-tetrahydrohomofolate
GB1419121A (en) Heterocyclic-fused triazole derivatives and their use in controlling plant pathogenic organisms
GB1295489A (en)
GB1252286A (en)
ES8402315A1 (en) Aminoglycoside derivatives, processes for their production, pharmaceutical compositions containing them and such derivatives for use as pharmaceuticals.
GB1361198A (en) Disulphide compounds and process for their manufa'ture
GB1350878A (en) Coumarin derivatives and production thereof
GB1512604A (en) Pharmaceutical compositions
GB1276061A (en) Tetronic acid derivatives, process for the manufacture thereof, and compositions containing such compounds
GB1314899A (en) Thiosemicarbazones processes for their preparations and compositions incorporating them
ES431943A1 (en) Cephalosporin derivatives
GB1252373A (en)
GB1381072A (en) 3-amino-as-triazino-6,5-quinoline and derivatives
GB1287433A (en) Pharmaceutical compositions
GB1214576A (en) Complexes having a prolonged adrenocorticotropic activity and process for their manufacture
GB994350A (en) Improvements in or relating to pteridine compounds and processes for their preparation
GB1175590A (en) Therapeutic Compositions
GB1509778A (en) Pharmaceutical composition and dosage units thereof
GB1230906A (en)
GB1464878A (en) Salts of 2,6-dioxocyclohexane thiocarboxylic acid 4-halo- anilides and pharmaceutical compositions thereof